Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2005-07-05
2005-07-05
Wilson, James O. (Department: 1623)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C536S027110, C536S027300, C536S027800, C536S027810, C536S028100
Reexamination Certificate
active
06914138
ABSTRACT:
Modified nucleosides and methods of making and using the nucleosides are disclosed. The compounds can be prepared by reacting nucleoside starting materials that contain a suitable leaving group at one or more of the carbon atoms in the purine or pyrimidine ring, with a vinylstannane, carbon monoxide, and a palladium catalyst to provide 1-ene-3-one intermediates. These intermediates are then reacted with suitably functionalized primary or secondary amines via a Michael reaction. When the intermediate is a 5-position modified pyrimidine ring, and the amine contains a second hydrogen, it can do a second Michael reaction with the ene-one or the ene-imine in the pyrimidine ring. Appropriate modification of the amine reactant can yield products with various bioactivities. The nucleosides can be used therapeutically as anti-cancer, anti-bacterial or anti-viral drugs. The nucleosides can also be used for diagnostic applications, for example, by incorporating a radiolabel or fluorescent label into the molecule. The nucleosides can be used to prepare oligonucleotides for use in various applications, either alone or in combination with other modified nucleosides and/or naturally occurring nucleosides.
REFERENCES:
patent: 4415732 (1983-11-01), Caruthers et al.
patent: 4725677 (1988-02-01), Köster et al.
patent: 4904582 (1990-02-01), Tullis
patent: 4923901 (1990-05-01), Koester et al.
patent: 4948882 (1990-08-01), Ruth
patent: 5023243 (1991-06-01), Tullis
patent: 5047519 (1991-09-01), Hobbs, Jr. et al.
patent: 5053499 (1991-10-01), Kojima et al.
patent: 5118672 (1992-06-01), Schinazi et al.
patent: 5118802 (1992-06-01), Smith et al.
patent: 5134066 (1992-07-01), Rogers et al.
patent: 5138045 (1992-08-01), Cook et al.
patent: RE34069 (1992-09-01), Köster et al.
patent: 5420276 (1995-05-01), Norbeck
patent: 5428149 (1995-06-01), Eaton
patent: 5580972 (1996-12-01), Tu et al.
patent: WO 90/15065 (1990-12-01), None
patent: WO 91/06556 (1991-05-01), None
patent: WO 91/06629 (1991-05-01), None
patent: WO 91/10671 (1991-07-01), None
patent: WO 91/14696 (1991-10-01), None
patent: WO 94/26761 (1994-11-01), None
Albano and Castellari (1990) Organometallics 9:1269.
Arai et al. (Jan. 1978) J. Am. Chem. Soc. 100:287.
Baillargeon and Stille (1983) J. Am. Chem. Soc. 105:7175.
Bergstrom et al. (1982) J. Org. Chem. 47:2174.
Bergstrom et al. (1981) J. Org. Chem. 46:1432.
Bergstrom et al. (Mar. 1976) J. Am. Chem. Soc. 98:1587.
Bigge and Mertes (1981) J. Org. Chem. 46:1994.
Brown and Cooley (1990) Organometallics 9:353.
Cadet and Teoule (1978) Photochemistry and Photobiology 28:661.
Cadet and Teoule (1974) Bull. Soc. Chim. 7:1565.
Comp. Organomet. Chem.(1982) 6:1003, Wilkinson, Stone & Abel, Editors, Pergamon Press.
Crisp (1989) Synthetic Communications 19:2117.
Crisp and Flynn (1990) Tetrahedron Letters 31:1347.
Crouch and Eaton (1994) Nucleosides & Nucleotides 13:939.
de Graaf et al. (1990) Organometallics 9:1479.
Dreyer and Dervan (1985) Proc. Natl. Acad. Sci. USA 82:968.
Englisch and Gauss (Jun. 1991) Angew. Chem. Int. Ed. Engl. 30:613.
Fukuda et al. (1986) Z. Naturforsch. 41b:1571.
Girault et al. (1994) Free Rad. Res. 20:315.
Guschlbauer et al. (Jun. 1977) Nucleic Acids Res. 4:1933.
Hacksell and Daves (1983) J. Org. Chem. 48:2870.
Hobbs et al. (1973) Biochemistry 12:5138.
Hung and Stock (1982) J. Org. Chem. 47:448.
Iida and Hayatsu (1971) Biochimica et Biophysica Acta 228:1.
Ikehara and Tada (1968)Synthetic Procedures in Nucleic Acid Chemistry, Zorbach, W.W.; Tipson, R.S. Eds.; John Wiley and Sons, NY p. 189.
Ono et al. (1994) Bioorg. & Med. Chem. Lett. 4:361.
Pieken et al. (Jul. 1991) Science 253:314.
Ross et al. (Jul.-Aug. 1994) J. Heterocyclic Chem. 31:765.
Ruth and Bergstrom (1978) J. Org. Chem. 43:2870.
Sagi et al. (1994) J. Med. Chem. 37:1307.
Scott and Stille (1986) J. Am. Chem. Soc. 108:3033.
Sentemov et al. (Sep. 1991) Chemical Abstracts 115:92415h.
Sessler et al. (1993) J. Am. Chem. Soc. 115:10418.
Shibahara et al. (1987) Nucleic Acids Res. 15:4403.
Sproat et al. (1989) Nucleic Acids Res. 17:3373.
Stille (1986) Angew. Chem. Int. Ed. Engl. 25:508.
Stille and Groh (1987) J. Am. Chem. Soc. 109:813.
Thiesen and Bach (1990) Nucleic Acids Res. 18:3203.
Tronchet et al. (1988) Nucleosides & Nucleotides, 7:249.
Tronchet et al. (1990) Tetrahedron Letters 31:531.
Van Aerschot et al. (1993) J. Med. Chem. 36:2938.
Yamamoto et al. (1989) J. Org. Chem. 54:4734.
Zhang et al. (1993) Organometallics 12:1499.
Agathocleous and Shaw (1991), J. Chem. Soc. Perkin Trans. 1 10:2317.
Eaton Bruce
Kirschenheuter Gary
Gilead Sciences, Inc.
Lewis Patrick T.
Swanson & Bratschun L.L.C.
Wilson James O.
LandOfFree
Urea nucleosides as therapeutic and diagnostic agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Urea nucleosides as therapeutic and diagnostic agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Urea nucleosides as therapeutic and diagnostic agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3390524